| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/19/1992 | EP0471205A1 Monoclonal antibodies which bind TRK proto-oncogene protein |
| 02/19/1992 | EP0471125A1 Modified protease, method of producing the same and cosmetic compositions containing the modified protease |
| 02/19/1992 | EP0471028A1 Highly cytopathogenic hiv-ndk retrovirus, dna fragments of this retrovirus, method for preparing a protein and/or an enzyme of this virus, and the applications of these |
| 02/19/1992 | EP0470974A1 Lytic peptides, use for growth, infection and cancer |
| 02/19/1992 | CN1058782A Epitheliins: novel cysteine-rich growth modulating proteins |
| 02/19/1992 | CN1058781A Pyrano heterocyclic anthracycline analogs |
| 02/18/1992 | WO1992003542A1 PROTEASES CAUSING ABNORMAL DEGRADATION OF AMYLOID β-PROTEIN PRECURSOR |
| 02/18/1992 | WO1992003478A1 Metal ion mediated receptor binding of polypeptide hormones |
| 02/18/1992 | US5089616 From 3-(2-amino-4-thiazolyl)-L-alanine, without protection of the aminothiazole group |
| 02/18/1992 | US5089603 Antigenic epitopes present on membrane-bound but not secreted iga |
| 02/18/1992 | US5089602 Process for the manufacture of apolipoproteins from human blood plasma or serum |
| 02/18/1992 | US5089492 Pharmaceuticals and dietetics containing acylamino acid derivatives |
| 02/18/1992 | US5089481 Polysaccharides and antiviral drugs containing the same as active ingredient |
| 02/18/1992 | US5089476 Glutamic acid derivatives |
| 02/18/1992 | US5089475 Administering of growth hormone |
| 02/18/1992 | US5089474 Solid phase synthesis, anti-elastase activity |
| 02/18/1992 | US5089473 Somatotropin variants and their use |
| 02/18/1992 | US5089472 Administering for short term memory or attention |
| 02/18/1992 | US5089409 Increasing proportion of neutral oligosaccharides in the tissue plasminogen glycoproteins |
| 02/18/1992 | US5089400 Recombinant DNA which produces lymphoblastoid interferon-like polypeptides, useful as immunomodulators |
| 02/18/1992 | US5089396 Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
| 02/18/1992 | US5089274 Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders |
| 02/18/1992 | US5089264 Method for treatment of bovine retained placenta |
| 02/18/1992 | US5089262 Diagnosis, therapy |
| 02/18/1992 | US5089260 Method of treating ischemic tissue |
| 02/18/1992 | CA2088776A1 Proteases causing abnormal degradation of amyloid .beta.-protein precursor |
| 02/18/1992 | CA2087267A1 Metal ion mediated receptor binding of polypeptide hormones |
| 02/18/1992 | CA2049390A1 Novel peptide derivatives and their pharmaceutical use |
| 02/18/1992 | CA1295940C Therapeutic treatment of abnormal cell growth with follicle regulatoryprotein |
| 02/17/1992 | WO1992003455A1 INHIBITION OF $i(CANDIDA) |
| 02/17/1992 | CA2089665A1 Inhibition of candida |
| 02/16/1992 | CA2048244A1 Monoclonal antibodies which bind trk proto-oncogene protein |
| 02/15/1992 | WO1992003454A1 Inhibition of influenza virus type a, ann arbor strain h2n2 by antisense oligonucleotides |
| 02/15/1992 | WO1992003148A1 Improved hypoglycemics |
| 02/15/1992 | WO1992003144A1 Protein structure of the plant toxin gelonin |
| 02/15/1992 | WO1992003125A1 Bone growth stimulator |
| 02/15/1992 | CA2089562A1 Inhibition of influenza virus type a, ann arbor strain h2n2 by antisense oligonucleotides |
| 02/15/1992 | CA2067738A1 Hypoglycemics |
| 02/14/1992 | WO1992003574A1 Cytokine production |
| 02/14/1992 | WO1992003551A1 Birch pollen allergen p14 for diagnosis and therapy of allergic diseases |
| 02/14/1992 | WO1992003476A1 Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
| 02/14/1992 | WO1992003466A1 Lymphokine 154 |
| 02/14/1992 | CA2089389A1 Cytokine production |
| 02/14/1992 | CA2089258A1 Lymphokine 154 |
| 02/14/1992 | CA2088972A1 Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
| 02/14/1992 | CA2088496A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 02/14/1992 | CA2067182A1 Birch pollen allergen p14 for diagnosis and therapy of allergic diseases |
| 02/14/1992 | CA2048953A1 Borolysine peptidomimetics |
| 02/13/1992 | DE4125188A1 Granulocyten hemmendes polypeptid Granulocyte inhibitory polypeptide |
| 02/13/1992 | DE4025499A1 Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen Use of antibodies BR55-2, derivatives thereof, and fragments conjugate on HIV infections |
| 02/12/1992 | EP0470586A1 Purified recombinant interleukin-2 compositions |
| 02/12/1992 | EP0470569A1 Intravascular embolizing agent containing angiogenesis inhibiting substance |
| 02/12/1992 | EP0470452A2 A method for the production of complexes of long chain polyunsaturated fatty acids and their derivatives, with cyclodextrins, and the resulting complexes |
| 02/12/1992 | EP0470256A1 Peptide derivatives and production thereof |
| 02/12/1992 | EP0470165A1 Fusion proteins containing n-terminal fragments of human serum albumin |
| 02/12/1992 | EP0470144A1 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours. |
| 02/12/1992 | EP0470128A1 Active carbonates of polyalkylene oxides for modification of polypeptides |
| 02/12/1992 | EP0470117A1 Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions. |
| 02/12/1992 | CN1058597A Process for enzymatic preparation of basic fibroblast growth factor |
| 02/11/1992 | US5087618 Antiviral, anticancer, antitumor agents |
| 02/11/1992 | US5087616 Linked by biodegradable polymer to epidermal growth factor |
| 02/11/1992 | US5087615 Novel method of ovulation induction in humans |
| 02/11/1992 | US5087614 Inhibits aspartic proteinases |
| 02/11/1992 | US5087613 Hirudin variants |
| 02/11/1992 | US5087573 Monoclonal antibody against bone alkaline phosphatase |
| 02/11/1992 | US5087572 Anticoagulants |
| 02/11/1992 | US5087569 Antimicrobial proteins, compositions containing same and uses thereof |
| 02/11/1992 | US5087562 Humoral hypercalcemic factor antagonists with modification at position 13 . . . |
| 02/11/1992 | US5087557 Human monoclonal antibody to lymphadenopathy-associated virus |
| 02/11/1992 | US5087453 Method for the treatment of bacterial caused weight loss and/or hypoglycemia |
| 02/11/1992 | US5087448 Enhancing growth of megakaryocytes in mammals using interleuking 6 |
| 02/11/1992 | US5087368 Purified protease nexin |
| 02/11/1992 | CA1295784C Peptide immunostimulants |
| 02/11/1992 | CA1295567C Expression system for the secretion of bioactive human granulocyte, macrophage-colony stimulating factor (gm-csf) and other heterologous proteins from streptomyces |
| 02/10/1992 | CA2047884A1 Method for the production of complexes of long chain polyunsaturated fatty acids and their derivatives, with cyclodextrins, and the resulting complexes |
| 02/09/1992 | WO1992002640A1 Cannabinoid receptor |
| 02/09/1992 | WO1992002621A2 Allergens of alder pollen and applications thereof |
| 02/09/1992 | CA2087844A1 Cannabinoid receptor |
| 02/09/1992 | CA2067144A1 Allergens of alder pollen and applications thereof |
| 02/07/1992 | WO1992002239A1 Stable hemoglobin based composition and method to store same |
| 02/06/1992 | WO1992001794A2 Ancrod-like proteins, their preparation and their use |
| 02/06/1992 | WO1992001789A1 Stable and bioactive modified somatotropins |
| 02/06/1992 | WO1992001783A1 Dna capable of site-specific integration into mycobacteria |
| 02/06/1992 | WO1992001718A2 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 02/06/1992 | WO1992001717A1 Bacterial stress proteins |
| 02/06/1992 | WO1992001716A1 Protease resistant pdgf and methods of use |
| 02/06/1992 | WO1992001710A1 Anticoagulant peptides |
| 02/06/1992 | WO1992001708A1 Vinylsulphonyl pristinamycin and preparation thereof |
| 02/06/1992 | WO1992001705A1 Plasmodium vivax and plasmodium knowlesi duffy receptor |
| 02/06/1992 | WO1992001703A1 Production of and compositions for the major cs1 pilin antigen including vaccines and diagnostic probes |
| 02/06/1992 | WO1992001694A1 New salts derived from dialkylaminoalkylsulphonyl-26 pristinamycin ii¿b? |
| 02/06/1992 | WO1992001473A1 Improved immunotherapeutic method of preventing or treating viral respiratory tract disease |
| 02/06/1992 | WO1992001471A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 02/06/1992 | WO1992001468A1 Endoserine converting enzyme inhibitor or vascular twitch remedy |
| 02/06/1992 | WO1992001466A1 Prophylactic and therapeutic applications of peroxidases |
| 02/06/1992 | WO1992001463A1 Stabilized somatotropin for parenteral administration |
| 02/06/1992 | WO1992001462A1 Amphiphilic peptide compositions and analogues thereof |
| 02/06/1992 | WO1992001459A1 Adoptive immunotherapy with interleukin-7 |
| 02/06/1992 | WO1992001442A1 Stable pharmaceutical compositions containing a fibroblast growth factor |
| 02/06/1992 | WO1992001440A1 Trans-mucosal drug preparations and trans-mucosal administration |